Explore critical topics shaping today’s SAP landscape—from digital transformation and cloud migration to cybersecurity and business intelligence. Each topic is curated to provide in-depth insights, best practices, and the latest trends that help SAP professionals lead with confidence.
Discover how SAP strategies and implementations vary across global markets. Our regional content brings localized insights, regulations, and case studies to help you navigate the unique demands of your geography.
Get industry-specific insights into how SAP is transforming sectors like manufacturing, retail, energy, and healthcare. From supply chain optimization to real-time analytics, discover what’s working in your vertical.
Dive into the most talked-about themes shaping the SAP ecosystem right now. From cross-industry innovations to region-spanning initiatives, explore curated collections that spotlight what’s trending and driving transformation across the SAP community.
Explore critical topics shaping today’s SAP landscape—from digital transformation and cloud migration to cybersecurity and business intelligence. Each topic is curated to provide in-depth insights, best practices, and the latest trends that help SAP professionals lead with confidence.
Discover how SAP strategies and implementations vary across global markets. Our regional content brings localized insights, regulations, and case studies to help you navigate the unique demands of your geography.
Get industry-specific insights into how SAP is transforming sectors like manufacturing, retail, energy, and healthcare. From supply chain optimization to real-time analytics, discover what’s working in your vertical.
Dive into the most talked-about themes shaping the SAP ecosystem right now. From cross-industry innovations to region-spanning initiatives, explore curated collections that spotlight what’s trending and driving transformation across the SAP community.
Compliance with the Drug Supply Chain Security Act (DSCSA) requires robust data exchange, interoperability, and serialization in pharmaceutical supply chains to ensure traceability and safety.
Companies preparing for DSCSA's enhanced traceability milestone must consider data management, interoperable systems, and the impacts of serialization on supply chain processes.
To achieve compliance with DSCSA regulations, companies must address key questions regarding integrated systems, suspect product handling, and investigation support while leveraging technology solutions like Movilitas.Cloud for enhanced supply chain visibility and regulatory compliance.
Discover how the FDA’s Drug Supply Chain Security Act (DSCSA) impacts pharmaceuticals. Understand compliance considerations, data exchange, interoperability, serialization, and more for November 27, 2023, deadline. Download our DSCSA Compliance Checklist for full traceability preparation. Engineering Industries Excellence offers Movilitas.Cloud for easy serialization and compliance, ensuring regulatory adherence and increased supply chain visibility.
A Closer Look at the Drug Supply Chain Security Act (DSCSA)
In the United States, the FDA’s Drug Supply Chain Security Act (DSCSA) outlines steps required by the Pharmaceuticals & Life Sciences industry to build an electronic, interoperable system to identify and trace prescription drugs as they are distributed. The deadline of November 27, 2023, has been implemented to protect consumers from counterfeit, stolen, contaminated or otherwise harmful products. The DSCSA also establishes the requirements to exchange all Transaction Information (TI) and Transaction Statements (TS) in a secure and electronic manner. The TI must include the unique product identifier at the package level for all the packages included within the transaction, including their hierarchies. This information should be kept in case a trace request is initiated by a state authority or the FDA. Aside from the TI/TS exchange, the requirement for manufacturers to respond to verification requests from distributors and dispensers has also been established. Upon request by an Authorized Trading Partner (ATP), the DSCSA also requires trading partners to have systems and processes in place to promptly respond to a verification request for a product.
DSCSA Compliance Considerations
There are several aspects companies need to consider while preparing for the DSCSA 2023 enhanced traceability milestone. This includes data management, the exchange of data between the trading partners, supply chain processes and the impacts of serialization and traceability.
The DSCSA requires a trading partner to provide TI to the subsequent owner of a product at the time of each transaction. With enhanced traceability, there will be a multitude of additional data captured, stored and exchanged between business partners and systems such as packaging lines and site servers, Enterprise Resource Planning (ERP) and Warehouse Management Systems (WMS). In addition to serialization and events data, the scope includes master and transaction data. To avoid any data inconsistency risks and gain business execution efficiencies in a serialization and traceability environment, it is crucial to have the other business process execution systems tightly integrated with the serialization and events repository.
Interoperability
Trading partners are required to provide an electronic and interoperable TI and TS to the downstream trading partners for each DSCSA-relevant transaction. The pharmaceutical supply chain stakeholder should start with the evaluation of the technical readiness and integration needs of their partner network to determine an onboarding strategy for partner exchanges. At times, onboarding a trading partner may require a lot of effort and time from the kick-off stage to exchange data within production environments. Level 5 serialization network solutions can help companies receive access to partners onboarded on the network and can cut the onboarding time and efforts drastically.
Serialization
Serialization has changed the way supply chain processes are executed today through the introduction of new systems and providing process optimization opportunities. For instance, in a serialized warehouse environment, there is a shift from scanning National Drug Codes (NDC) and entering the quantity to ensuring each of the unique product identifiers are validated and captured. In this case, change management is crucial to driving the successful adoption and usage of changes within the business.
Pharmaceutical companies must ensure they have defined the operations and systems in place to support all DSCSA requirements such as verification requests from authorized trading partners, product identification, and product traceability.
Questions to Ask Yourself
In terms of IT landscapes and operations, the following questions are useful questions to ask yourself when assessing your DSCSA readiness.
Have you validated the performance of integrated systems that supports critical business operations such as Serialized Warehouse Operations?
Do you have systems in place to remove suspect and/or illegitimate products from the supply chain and notify the relevant parties?
Are your systems enabled to handle non-serialized, serialized, and serialized and aggregated products efficiently and simultaneously?
Have you defined the processes to address any verification requests from trading partners or Governmental Agencies?
Have you defined systems and are they equipped to support investigations efficiently?
While planning for the compliance deadline of November 27, 2023, be sure to review our DSCSA checklist.
To get a copy of the complete checklist, download it here.
How to Prepare for Full-Traceability
With so many changes coming in the very near future, it is key to evaluate now what next steps your company needs to follow until November 2023. Technology will be the driver to ensure compliance and should be selected based on your company and market needs.
Supporting the 14 out of the 20 largest pharmaceutical companies, Engineering Industries Excellence offers roadmap guidance, our Movilitas.Cloud solution knowledge and track & trace expertise so customers can benefit from increased supply chain visibility along with full regulatory compliance. Movilitas;Cloud provides a corporate serialization repository and serial number management with reporting, and offers companies a secure way to ensure complete compliance for upcoming DSCSA regulations. Movilitas.Cloud is a top choice solution for pharmaceutical enterprises, enabling easy data-sharing with multiple stakeholders to simplify compliance and avoid exclusion in key global markets.
Engineering’s Expertise
While new regulations can be a challenge to understand and implement, there are many benefits to becoming compliant within the industry that Engineering Industries eXcellence can help with. Our cloud-based and Software-as-a-Service solution, Movilitas.Cloud, is easy-to-use and highly configurable. The application’s Serialized Manufacturing and Serialized Logistics helps enable businesses to make serialization and compliance easy. The strong technical expertise, profound industry knowledge and successful delivery record of our Track & Trace specialists makes Engineering Industries eXcellence a power player in the arena of serialized manufacturing and logistics. We will continue our mission for digital transformation to help industrial enterprises meet the demands of today’s dynamic economy.